When we evaluated the levels of RBMX and YTHDC1 in CLL patients, we observed a positive correlation between YTHDC1 and RBMX or circTET2, as well as between circTET2 and RBMX (Figure 4I,K). Here, YTHDC1 is linked to B-cell chronic lymphocytic leukemia.